يعرض 1 - 20 نتائج من 81 نتيجة بحث عن '"E I Samokhvalov"', وقت الاستعلام: 0.83s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
  3. 3
    Academic Journal
  4. 4
  5. 5
  6. 6
    Academic Journal

    المصدر: CHILDREN INFECTIONS; Том 16, № 4 (2017); 17-21 ; ДЕТСКИЕ ИНФЕКЦИИ; Том 16, № 4 (2017); 17-21 ; 2618-8139 ; 2072-8107 ; 10.22627/2072-8107-2017-16-4

    وصف الملف: application/pdf

    Relation: https://detinf.elpub.ru/jour/article/view/320/309; Daw M.A., El-Bouzedi A.A., Ahmed M.O., Dau A.A., Agnan M.M., Drah A.M. Geographic integration of hepatitis C virus: A global threat. World J. Virol. 2016; 5(4):170—182.; Petruzziello A., Marigliano S., Loquercio G., Cozzolino A., Cacciapuoti C. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J. Gastroenterol. 2016; 22(34):7824—7840.; Пименов Н.Н., Чуланов В.П., Комарова С.В., Карандашова И.В., Неверов А.Д., Михайловская Г.В., Долгих В.А., Лебедева Е.Б., Пашкина К.В., Коршунова Г.С. Гепатит С в России: эпидемиологическая характеристика и пути совершенствования диагностики и надзора. Эпидемиология и инфекционные болезни. 2012; 17(3): 4—10. [Pimenov N.N., Chulanov V.P., Komarova S.V., Karandashova I.V., Neverov A.D., Mikhaylovskaya G.V., Dolgikh V.A., Lebedeva E.B., Pashkina K.V., Korshunova G.S. Hepatitis C in Russia: epidemiological characteristics and ways to improve diagnostics and surveillance. Epidemiologiya i Infectsionniy bolezni = Epidemiology and Infection Diseases. 2012; 17(3): 4—10. (In Russ)]; Mukomolov S., Trifonova G., Levakova I., Bolsun D., Krivanogova E. Hepatitis C in the Russian Federation: challenges and future directions. Hepat. Med. 2016; 8: 51—60.; Кистенёва Л.Б., Чешик С.Г., Самохвалов Е.И., Серобян А.Г., Малышев Н.А. Перинатальный гепатит С: комплексная оценка факторов риска. Российский вестник перинатологии и педиат- рии. 2012; 2: 58—63. [Kistenyova L.B., Cheshik S.G., Samokhvalov E.I., Serobyan A.G., Malyshev N.A. Perinatal hepatitis C: comprehensive assessment of risk factors. Possiyskiy Vestnik Perinatologii i Pediatrii = The Russian Herald of Perinatology and Pediatrics. 2012; 2: 58—63. (In Russ)]; Tanaka T., Lau J., Mizokami M., Orito E., Tanaka E., Kiyosawa K., Yasui K., Ohta Y., Hasegawa A., Tanaka S. Simple fluorescent enzyme immunoassay for detection and quantification of Hepatitis C viremia. J. Hepatol. 1995; 23(6): 742—745.; Aoyagi K., Ohue C., Iida K., Kimura T., Tanaka E., Kiyosawa K., Yagi S. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J. Clin Microbiol. 1999; 37: 1802—1808.; Icardi G., Bruzzone B., Gota F., Torre F., Giannini E., Massone L., Li Bassi A., Lai P.L., Picciotto A, Ansaldi F. A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects? Ann. Ig. 2003; 15(6): 863—870.; Morota K., Fujinami R., Kinukawa H., Machida T., Ohno K., Saegusa H., Takeda K. A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigen. J. Virol. Methods. 2009; 157(1): 8—14.; Ross R.S., Viazov S., Salloum S., Hilgard P., Gerken G., Roggendorf M. Analytical performance characteristics and clinical utility of a novel assay for total hepatitis C virus core antigen quantification. Clin. Microbiol. 2010; 48(4): 1161—1168.; Perlemuter G., Sabile A., Letteron P., Vona G., Topilco A., Chrétien Y., Koike K., Pessayre D., Chapman J., Barba G., Bréchot C. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J. 2002;16(2): 185—194.; Korenaga M., Wang T., Li Y., Showalter L.A., Chan T., Sun J., Weinman S.A. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ros) production. J. Biol. Chem. 2005; 280: 37481—37488.; Stone A.E., Mitchell A., Brownell J., Miklin D.J., Golden-Mason L., Polyak S.J., Gale M.J.Jr, Rosen H.R. Hepatitis C virus core protein inhibits interferon production by a human plasmacytoid dendritic cell line and dysregulates interferon regulatory factor-7 and signal transducer and activator of transcription (STAT) 1 protein expression. PLoS One. 2014; 9(5): 1—9.; Benzoubir N., Lejamtel C., Battaglia S., Testoni B., Benassi B., Gondeau C., Perrin-Cocon L., Desterke C., Thiers V., Samuel D., Levrero M., Bréchot C., Bourgeade M.F. HCV core-mediated activation of latent TGF- via thrombospondin drives the crosstalk between hepatocytes and stromal environment. J. Hepatol. 2013; 59(6): 1160—1168.; Yamanaka T., Kodama T., Doi T. Subcellular localization of HCV core protein regulates its ability for p53 activation and p21 suppression. Biochem. Biophys. Res. Commun. 2002; 294(3): 528— 534.; Park Y., Lee J.H., Kim B.S., Kim D.Y., Han K.H., Kim H.S. New automated hepatitis C virus (HCV) core antigen assay as an alternative to Real-Time PCR for HCV RNA quantification. J. Clin. Microbiol. 2010; 48(6): 2253—2256.; Tedder R.S., Tuke P., Wallis N., Wright M., Nicholson L., Grant P.R. Therapy-induced clearance of HCV core antigen from plasmapredicts an end of treatment viral response. J. Viral Hepatitis. 2013; 20: 65—71.; Ergünay K., Sener B., Alp A., Karakaya J., Hasçelik G. Utility of a commercial quantitative hepatitis C virus core antigen assay in a diagnostic laboratory setting. Diagn Microbiol Infect Dis. 2011; 70(4): 486—491.; Wang L., Lv H., Zhang G. Hepatitis C virus core antigen assay: an alternative method for hepatitis C diagnosis. Ann. Clin. Biochem. 2017; 54(2): 79—85.; Hadziyannis E., Minopetrou M., Georgiou A., Spanou F., Koskinas J. Is HCV core antigen a reliable marker of viral load? An evaluation of HCV core antigen automated immunoassay. Ann. Gastroenterol. 2013; 26(2): 146—149.; Bouvier-Alias M., Patel K., Dahari H., Beaucourt S., Larderie P., Blatt L., Hezode C., Picchio G., Dhumeaux D., Neumann A.U., McHutchison J.G., Pawlotsky J.M. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology. 2002; 36(1): 211—218.; Murayama A.A., Sugiyama N., Watashi K., Masaki T., Suzuki R., Aizaki H., Mizuochi T., Wakita T., Kato T. Japanese reference panel of blood specimens for evaluation of hepatitis C virus RNA and core antigen quantitative assays. Clin. Microbiol. 2012; 50(6): 1943— 1949.; Nguyen L.T., Dunford L., Freitas I., Holder P., Nguyen L.A., O'Gorman J., Connell J., Carr M., Hall W., De Gascun C. Hepatitis C virus core mutations associated with false-negative serological results for genotype 3a core antigen. J. Clin. Microbiol. 2015; 53(8): 2697— 2700.; Budkowska A., Kakkanas A., Nerrienet E., Kalinina O., Maillard P., Horm S.V., Dalagiorgou G., Vassilaki N., Georgopoulou U., Martinot M., Sall A.A., Mavromara P. Asynonymous mutations in the core gene are linked to unusual serological profile in hepatitis C virus infection. Plos One. 2011; 6(I1); e15871.; Nikolaeva L.I., Leybman E.A., Samokhvalov E.I., Kyuregyan K.K., Isaeva O.V., Kichatova V.K., Mikhailov M.I. Hepatitis C virus isolate Chu_1a core protein gene, partial cds. GenBank. 2014; KM05444515.; Nikolaeva L.I., Leybman E.A., Samokhvalov E.I., Kyuregyan K.K., Isaeva O.V., Kichatova V.K., Mikhailov M.I. Hepatitis C virus isolate Kul_2k/1b core protein gene, partial cds. GenBank. 2014; KM05444516.; Iijima A., Tanaka E., Kobayashi M., Yagi S., Mizokami M., Kiyosawa K. Relationship between histological prognosis of chronic hepatitis C and amount of hepatitis C virus core protein in serum. J. Gastroenterol. Hepatol. 2000; 15: 311—319.; Durante-Mangoni Е., Vallefuoco L., Sorrentino R., Iossa D., Perna E., Molaro R., Braschi U., Zampino R., Sodano G., Adinolfi L.E., Utili R., Portella G. Clinico-pathological significance of hepatitis C virus core antigen levels in chronic infection. J. Med. Virol. 2013; 85:1 913—1918.; Масолова О.В. Вирусный гепатит С: новые подходы к изучению патогенеза и разработка средств диагностики и профилактики. Автореф. дис. … дбн. М., 2011: 46. [Masolova O.V. Viral hepatitis C: new approaches to the study of pathogenesis and the development of diagnostic tools and prevention: Abstract of MD Thesis (Biol.). M, 2011: 46. (In Russ)].; Easterbrook P.J. Who to test and how to test for chronic hepatitis C infection. J. Hepatol. 2016; 65(1 Suppl): 46—66.; EASL (European Association for Study of Liver). Recommendations on Treatment of Hepatitis C — 2016. J. Hepatol. 2017; 66: 153—194.; https://detinf.elpub.ru/jour/article/view/320

  7. 7
    Academic Journal

    المصدر: CHILDREN INFECTIONS; Том 12, № 4 (2013); 27-30 ; ДЕТСКИЕ ИНФЕКЦИИ; Том 12, № 4 (2013); 27-30 ; 2618-8139 ; 2072-8107 ; 10.22627/2072-8107-2013-12-4

    وصف الملف: application/pdf

    Relation: https://detinf.elpub.ru/jour/article/view/151/151; Этиологическая структура циррозов печени у детей / С.Б. Чуелов и др. // Детские инфекции. — 2008. — Т. 7. — № 1. — С. 14— 18.; Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time? / M. Guido et al. et al. // Am. J. Gastrotnterоl. — 2003. — V. 98. — P. 660—663.; Hepatitis C virus infection acquired in childhood / С. Camarero et al. // Eur J Pediatr. — 2008. — 167 (2). — Р. 219—224.; Chronic hepatitis C in Israeli children / Е. Broide et al. // Fetal Pediatr Pathol. — 2004. — 23 (4). — Р. 231—239.; Chronic hepatitis C in childhood: an 18-year experience / R. Iorio et al. // Clin Infect Dis. — 2005. — 41. — Р. 1431—1437.; Chronic hepatitis C in children-review of natural history at a National Centre / M. Abdel-Hady et al. // M J. Viral Hepat. — 2011. — 18 (10). — Р. 535—540.; Symptomatic and Pathophysiologic Predictors of Hepatitis C Virus Progression in Pediatric Patients / W. A. Henderson, R. Shankar, J. J. Feld, C. M. Hadigan // The Pediatric Infectious Disease Journal. — 2009. — V 28 (№ 8). — Р. 723—725.; Histopathology of the liver in children with chronic hepatitis C viral infection / K. Badizadegan et al. // Hepatology. — 1998. — 28 (5). — Р. 1416—1423.; Pathology of chronic hepatitis C in children. Child Liver Study Group of Japan / M. Kage et al. // Hepatology. — 1997. — 26 (3). — Р. 771—775.; Течение гепатита С у детей / О.В. Молочкова, Т.В. Чередниченко, М.О. Гаспарян, Г.В. Чаплыгина // Детские инфекции. — 2002. — Т. 4. — № 1. — С. 21—23.; Chronic hepatitis C virus infection in childhood: Clinical patterns and evolution in 224 white children / P. Jara et al. // Clinical Infectious Diseases. — V. 36. — Issue 3. — 2003. — P. 275—280.; R. Moreno-Otero. Liver histology damage in children with chronic hepatitis C / R. Moreno-Otero, M. Trapero, P. Jara // Pediatr Infect Dis J. — 2010. — 29 (2). — Р. 189—90.; M.M. Jonas. Children with hepatitis C // Hepatology. — 2002. — 36 (5 Suppl 1) : S. 173—178.; П.Н. Филимонов. Патоморфология хронических сочетанных вирусных гепатитов у детей: Автореф. дисс. . доктор медицинских наук — Новосибирск, 2005.; Influence of body mass index on outcome of pediatric chronic hepatitis C virus infection / A. Delgado-Borrego et al. // J. Pediatr Gastroenterol Nutr. — 2010. — 51. — Р. 191—197.; Role of hepatitis C virus genotype 3 in liver fibrosis progressiona systematic review and meta-analysis /A. Probst et al. // J. Viral Hepat. — 2011. — 18 (11). — Р. 745—759.; Частота встречаемости отдельных субтипов вируса гепатита С в Московском регионе / Е.И. Самохвалов и др. // Вопр. вирусологии. — 2013. — Т. 58. — № 1. — С. 36—39.; Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease / F. Bortolotti et al. // Gastroenterology. — 2008. — 134 (7). — Р. 1900—1907.; https://detinf.elpub.ru/jour/article/view/151

  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20